We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRPT icon
426
Freshpet
FRPT
$3.5B
$6.56M 0.03%
78,914
-13,743
-15% -$1.68M
CWK icon
427
Cushman & Wakefield Ltd
CWK
$3.37B
$6.55M 0.03%
641,094
-195,094
-23% -$2.37M
JBHT icon
428
JB Hunt Transport Services
JBHT
$26.5B
$6.55M 0.03%
44,248
+34,281
+344% +$5.64M
TUYA
429
Tuya Inc
TUYA
$1.12B
$6.49M 0.03%
2,143,529
+613,238
+40% +$1.81M
CAKE icon
430
Cheesecake Factory
CAKE
$5.57B
$6.48M 0.03%
+133,153
New +$6.82M
LULU icon
431
lululemon athletica
LULU
$13.6B
$6.45M 0.03%
+22,782
New +$8.36M
YETI icon
432
Yeti Holdings
YETI
$3.44B
$6.43M 0.03%
194,404
+95,311
+96% +$3.45M
FOLD
433
DELISTED
Amicus Therapeutics
FOLD
$6.42M 0.03%
786,234
+483,698
+160% +$4.48M
YEXT icon
434
Yext
YEXT
$613M
$6.37M 0.03%
1,034,100
+185,116
+22% +$1.2M
RVMD icon
435
Revolution Medicines
RVMD
$43.3B
$6.36M 0.03%
179,762
-28,639
-14% -$1.16M
ACH
436
Accendra Health
ACH
$84.6M
$6.35M 0.03%
703,050
+401,472
+133% +$4.24M
WOR icon
437
Worthington Enterprises
WOR
$2.85B
$6.35M 0.03%
126,725
+48,045
+61% +$2.03M
TU icon
438
Telus
TU
$15.2B
$6.34M 0.03%
442,082
-2,647,564
-86% -$38.8M
GDRX icon
439
GoodRx Holdings
GDRX
$1.27B
$6.33M 0.03%
1,434,625
+205,789
+17% +$966K
AXGN icon
440
Axogen
AXGN
$2.58B
$6.28M 0.03%
339,711
+50,966
+18% +$920K
HLF icon
441
Herbalife
HLF
$1.28B
$6.25M 0.03%
723,968
+113,015
+18% +$804K
CMRC
442
Commerce.com Inc Series 1
CMRC
$184M
$6.24M 0.03%
1,083,965
+387,836
+56% +$2.46M
ITRI icon
443
Itron
ITRI
$4.5B
$6.23M 0.03%
59,503
+40,693
+216% +$4.26M
OLN icon
444
Olin
OLN
$2.17B
$6.23M 0.03%
257,131
+174,994
+213% +$4.92M
IMVT icon
445
Immunovant
IMVT
$8.64B
$6.22M 0.03%
364,229
+128,345
+54% +$2.68M
XPER icon
446
Xperi
XPER
$320M
$6.21M 0.03%
804,956
+208,709
+35% +$1.83M
SIG icon
447
Signet Jewelers
SIG
$3.6B
$6.19M 0.03%
+106,654
New +$6.11M
NBIX icon
448
Neurocrine Biosciences
NBIX
$15.3B
$6.18M 0.03%
55,865
-7,717
-12% -$978K
KSS icon
449
Kohl's
KSS
$2.22B
$6.17M 0.03%
754,478
-188,937
-20% -$2.19M
HOUS
450
DELISTED
Anywhere Real Estate
HOUS
$6.17M 0.03%
1,851,748
+159,046
+9% +$563K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.